trial

The study adhered to the ethical principles of the Declaration of Helsinki33 and followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guideline. Ethical approval for this study …

Specialty Please choose I’m not a medical professional. Allergy and Immunology Anatomy Anesthesiology Biostatistics Cardiac/Thoracic/Vascular Surgery Cardiology Critical Care Dentistry Dermatology Diabetes and Endocrinology Emergency Medicine Epidemiology and Public Health …

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet …

In this week’s issue of The Savvy Diabetic:  1st Rapid-Acting Biosimilar Insulin Approved UVa AI-Powered Insulin Delivery Susvimo for Diabetic Macular Edema Oral Insulin Prevention Trial (PDF) GLP-1 Agonists Increased …

Britain's NHS is launching the world's first trial of a “revolutionary” artificial intelligence tool that can identify patients at risk of type 2 diabetes more than a decade before the …

Design This study uses a hybrid type I effectiveness-implementation trial design [26] to test the effectiveness of LISTEN in a two-arm pragmatic, individual-level randomised controlled trial (RCT). We will simultaneously …

An ongoing Phase I/II clinical trial is evaluating VX-880 as a treatment for type 1 diabetes (T1D). Image courtesy of Ahmet Misirligul/Shutterstock. Vertex Pharmaceuticals The company announced positive data from …

RAPID CITY, S.D. (KOTA) – A new clinical trial conducted by the American Indian Clinical Trials Research Network in Rapid City will test a new drug to treat diabetic peripheral …

The Behavioral Diabetes Institute is piloting a new diabetes education program for adults with type 2 diabetes across the United States. Participants receive financial compensation, diabetes supplies, and a personalized …

The Behavioral Diabetes Institute is piloting a new diabetes education program for adults with type 2 diabetes across the United States. Participants receive financial compensation, diabetes supplies, and a personalized …